---
title: "Procept BioRobotics posts investor presentation outlining Aquablation growth strategy in BPH market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291175609.md"
description: "Procept BioRobotics released an investor presentation detailing its strategy to position Aquablation as a leading surgical treatment for Benign Prostatic Hyperplasia (BPH). The company estimates the U.S. BPH market at 40 million men with 400,000 annual procedures, noting current Aquablation penetration is around 10%. With over 125,000 patients treated globally, Procept highlighted that Category I reimbursement will be effective by January 1, 2026."
datetime: "2026-06-29T17:16:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291175609.md)
  - [en](https://longbridge.com/en/news/291175609.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291175609.md)
generator: "portal-rs"
---

# Procept BioRobotics posts investor presentation outlining Aquablation growth strategy in BPH market

-   Procept outlined a strategy to shift Aquablation from an established option to a leading surgical treatment for BPH. \* Management sized the U.S. BPH opportunity at about 40 million men, with roughly 400,000 surgical procedures annually. \* Aquablation penetration estimated at about 10% of the surgical market. \* Install base growth supported more than 125,000 patients treated worldwide. \* Category I reimbursement cited as in place as of Jan. 1, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Procept Biorobotics Corporation published the original content used to generate this news brief on June 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [PRCT.US](https://longbridge.com/en/quote/PRCT.US.md)

## Related News & Research

- [06:18 ETPRCT INVESTOR ALERT: PROCEPT BioRobotics Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit](https://longbridge.com/en/news/296212632.md)
- [04:35 ETPROCEPT BioRobotics Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PRCT](https://longbridge.com/en/news/296589247.md)
- [PROCEPT BioRobotics to present at Baird Global Healthcare Conference](https://longbridge.com/en/news/296102181.md)
- [PROCEPT BioRobotics Corporation (PRCT) Investors: September 22, 2026 Lead Plaintiff Deadline in Class Action Lawsuit](https://longbridge.com/en/news/296500440.md)
- [13:12 ETPRCT DEADLINE: Levi & Korsinsky Reminds PROCEPT BIOROBOTICS CORPORATION Investors of Upcoming Securities Class Action Deadline](https://longbridge.com/en/news/296384321.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**